PHARMA AND HEALTHCARE · NIFTY 50
CIPLA
NSE: CIPLA
As of 03:58 pm IST · NSE
Goodreturns · 298h ago
Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock? - GoodreturnsCipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock? - Goodreturns
NiftyTrader · 2342h ago
Cipla’s India Business Just Hit a Record — So Why Did Profit Crash 39%? - NiftyTraderCipla’s India Business Just Hit a Record — So Why Did Profit Crash 39%? - NiftyTrader
TechGraph · 1145h ago
Cipla (CIPLA) Share Price Today, Live Chart & News - TechGraphCipla (CIPLA) Share Price Today, Live Chart & News - TechGraph
AD HOC NEWS · 180h ago
Macquarie raises target for Cipla stock from INR 1,675 to INR 1,730 - AD HOC NEWSMacquarie raises target for Cipla stock from INR 1,675 to INR 1,730 - AD HOC NEWS
Business Standard · 2318h ago
Cipla shares rise 3.5% after Q1; brokerages cautious, trim target - Business StandardCipla shares rise 3.5% after Q1; brokerages cautious, trim target - Business Standard
Moneycontrol.com · 2318h ago
Cipla stocks gain 2.5% as Q1 profit jumps 42% QoQ; here's what Motilal Oswal says - Moneycontrol.comCipla stocks gain 2.5% as Q1 profit jumps 42% QoQ; here's what Motilal Oswal says - Moneycontrol.com
Upstox · 830h ago
Cipla, Vardhaman Textiles and Siemens Energy India shares cross 200 EMA despite weak market sentiment - UpstoxCipla, Vardhaman Textiles and Siemens Energy India shares cross 200 EMA despite weak market sentiment - Upstox
India Infoline · 2342h ago
Cipla Share Price Falls Over 3% After Q1 FY27 Results Disappoint Investors; Profit Drops 39% - India InfolineCipla Share Price Falls Over 3% After Q1 FY27 Results Disappoint Investors; Profit Drops 39% - India Infoline
Quotes may be delayed. For information only, not investment advice. Verify with NSE/BSE filings before acting.